The Maintenance Treatment of "ITIVA" in AML Patients

Abroad (travel likely)Recruiting

Conditions

Acute Myeloid Leukemia · Maintenance Treatment · Minor Residue Disease · Interferon-α-1b · Interleukin-2 · Thalidomide · Venentoclax · Azacitidine

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, Henan, China

    Contact: Study coordinator (Lin Wang, Doctor) · 13020025628@163.com · +8613203739652
Study leads
  • Xudong None Wei, Doctor/Professor

    Principal Investigator

    Cancer Hospital of Henan Province